DISEASE INDICATIONS: Gynaecological Cancer
MANUFACTURER: Tesaro UK Limited
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Zejula is primarily indicated for the treatment of ovarian cancer and, in some cases, breast cancer.
